Frequently Bought Together
Product Properties
|
Property Name |
Property Details |
|
Alternative Names |
FGF-8, FGF 8, FGF-8a, FGF8a |
|
Species |
Human |
|
Expression Region |
Gln23–Arg204 |
|
Accession |
P55075-2 |
|
Tag |
No Tag |
|
Expression System |
E. coli |
|
Molecular Weight |
The protein has a predicted MW of 21.20 kDa, same as SDS-PAGE result. |
|
Purity |
> 95% as determined by SDS-PAGE. |
|
Endotoxin |
< 1.0 EU per μg by the LAL method. |
|
Formulation |
Lyophilized from 0.22 μm filtered solution in 20 mM Tris-HCl, 300 mM NaCl (pH 8.5). Normally 8% mannitol is added as protectant before lyophilization. |
|
Appearance |
Lyophilized Powder |
|
Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water. |
Features
High purity, high bioactivity, low endotoxin, excellent lot-to-lot consistency
Storage
Store at -25°C to -15°C, valid for 1 year upon receipt.
After reconstitution, store at -85°C to -65°C, valid for 3 months.
Storage
FAQ
Citations
Documents
Applications
Sie können auch mögen
Anfrage
FAQ
Das Produkt ist nur für Forschungszwecke bestimmt und nicht für die therapeutische oder diagnostische Anwendung bei Menschen oder Tieren. Produkte und Inhalte sind durch Patente, Marken und Urheberrechte von
Für bestimmte Anwendungen sind möglicherweise zusätzliche geistige Eigentumsrechte Dritter erforderlich.